{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T01:55:34Z","timestamp":1765072534005,"version":"3.46.0"},"reference-count":15,"publisher":"BMJ","issue":"Suppl 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[1996]]},"abstract":"<jats:p>Hepatitis B vaccination strategies may vary from country to country depending on hepatitis B virus (HBV) endemicity, predominant modes of infection, age of infection, and health care resources. In areas with high endemicity like Korea, transmission of virus from carrier mothers to infants during the perinatal period, and from other horizontal sources to infants and children, account for most cases of HBV infection. The consequences of HBV infection at an early age are serious, as more than 70% remain chronic carriers of the virus. These chronic carriers are the principal source of infection for other susceptible people, and are themselves at high risk of developing other serious diseases, such as chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Theoretically, therefore, routine infant immunisation supplemented with prenatal screening of pregnant women for HBsAg or HBeAg and mass immunisation of children is the appropriate strategy for control of hepatitis B in these countries. To prevent primary liver cancer associated with HBV infection, however, immunisation of adults at high risk would also be prudent. Mandatory vaccination of all neonates is recommended in highly endemic areas, together with hepatitis B immune globulin in babies born to HBsAg carrier mothers.<\/jats:p>","DOI":"10.1136\/gut.38.suppl_2.s63","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T17:41:31Z","timestamp":1190137291000},"page":"S63-S66","source":"Crossref","is-referenced-by-count":26,"title":["Strategy for vaccination against hepatitis B in areas with high endemicity: focus on Korea."],"prefix":"10.1136","volume":"38","author":[{"given":"Y O","family":"Ahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1996,1,1]]},"reference":[{"key":"ref_1","first-page":"443","article-title":"Progress in the control of viral hepatitis: memorandum from a WHO meeting","volume":"66","author":"Organization, World Health","year":"1988","unstructured":"World Health Organization. Progress in the control of viral hepatitis: memorandum from a WHO meeting. Bull WHO 1988; 66: 443.","journal-title":"Bull WHO"},{"key":"ref_2","first-page":"1","article-title":"Disease Control. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP)","volume":"13","author":"for, Center","year":"1991","unstructured":"Center for Disease Control. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). M IWR 1991; 40 (RR-13): 1.","journal-title":"M IWR"},{"issue":"3","key":"ref_3","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/clinids\/11.Supplement_3.S574","article-title":"Global control of hepatitis B through vaccination: role of hepatitis B vaccine in the Expanded Programme on Immunization","volume":"11","author":"Maynard, J.E.; Kane, M.A.; Hadler, S.C.","year":"1989","unstructured":"Maynard JE, Kane MA, Hadler SC. Global control of hepatitis B through vaccination: role of hepatitis B vaccine in the Expanded Programme on Immunization. Rev Infect Dis 1989; 11 (S3): S574.","journal-title":"Rev Infect Dis"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0264-410X(93)90222-J","article-title":"Vaccination against hepatitis B: the Italian strategy","volume":"11","author":"Zanetti, A.R.; Tanzi, E.; Romano, L.; Grappasoni, I.","year":"1993","unstructured":"Zanetti AR, Tanzi E, Romano L, Grappasoni I. Vaccination against hepatitis B: the Italian strategy. Vaccine 1993; 11: 521.","journal-title":"Vaccine"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0264-410X(90)90232-B","article-title":"FB and the North American Regional Study Group. Controlling hepatitis B virus transmission in North America","author":"Hollinger","year":"1990","unstructured":"Hollinger FB and the North American Regional Study Group. Controlling hepatitis B virus transmission in North America. Vaccine 1990; 8 (Si): S122.","journal-title":"Vaccine"},{"key":"ref_6","first-page":"83","article-title":"Survey of licensed hepatitis B vaccines and their production processes","volume-title":"vaccines in clinical practice","author":"Sitrin, R.D.; Wampler, D.U.; Ellis, R.W.","year":"1993","unstructured":"Sitrin RD, Wampler DU, Ellis RW. Survey of licensed hepatitis B vaccines and their production processes. In: Ellis RW, ed. Hepatitis B vaccines in clinical practice. New York: Marcel Deckker, 1993: 83-101."},{"key":"ref_7","first-page":"383","article-title":"Potential future recombinant vaccines","volume-title":"vaccines in clinical practice","author":"B, Ellis RWHepatitis","year":"1993","unstructured":"Rutgers T, Hauser P, Wilder MD. Potential future recombinant vaccines. In: Ellis RW, ed. Hepatitis B vaccines in clinical practice. New York: Marcel Deckker, 1993: 383-9."},{"key":"ref_8","first-page":"351","article-title":"Application of synthetic peptide technology to experimental HBV vaccine design","volume-title":"vaccines in clinical practice","author":"Milich, DR","year":"1993","unstructured":"Milich DR. Application of synthetic peptide technology to experimental HBV vaccine design. In: Ellis RW, ed. Hepatitis B vaccines in clinical practice. New York: Marcel Deckker, 1993: 351-4."},{"key":"ref_9","first-page":"105","article-title":"Hepatitis B virus infection rate among Koreans","volume":"33","author":"Ahn, Y.O.; Kim, Y.S.; Lee, M.S.; Shin, M.H.","year":"1992","unstructured":"Ahn YO, Kim YS, Lee MS, Shin MH. Hepatitis B virus infection rate among Koreans. Seoul J Med 1992; 33: 105-44.","journal-title":"Seoul J Med"},{"key":"ref_10","first-page":"148","article-title":"Epidemiology of hepatitis B virus infection","volume-title":"vaccines in clinical practice","author":"Hadler, S.C.; Margolis, H.S.","year":"1993","unstructured":"Hadler SC, Margolis HS. Epidemiology of hepatitis B virus infection. In: Ellis RW, ed. Hepatitis B vaccines in clinical practice. New York: Marcel Deckker, 1993: 148-9."},{"key":"ref_11","first-page":"243","article-title":"Longitudinal study on the negative conversion rate of HBsAg among male adults in Korea","volume":"30","author":"Park, B.J.","year":"1989","unstructured":"Park BJ. Longitudinal study on the negative conversion rate of HBsAg among male adults in Korea. SeoulJtMed 1989; 30: 243-8.","journal-title":"SeoulJtMed"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3346\/jkms.1994.9.6.444","article-title":"Familial clustering of hepatitis B and C viruses in Korea","volume":"9","author":"Kim, Y.S.; Ahn, Y.O.; Kim, D.W.","year":"1994","unstructured":"Kim YS, Ahn YO, Kim DW. Familial clustering of hepatitis B and C viruses in Korea. J Korean Med Sci 1994; 9: 444-9.","journal-title":"J Korean Med Sci"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3346\/jkms.1993.8.6.395","article-title":"Factors associated with intrafamilial transmission of hepatitis B virus infection in Korea","volume":"8","author":"Kim, Y.S.; Ahn, Y.O.","year":"1993","unstructured":"Kim YS, Ahn YO. Factors associated with intrafamilial transmission of hepatitis B virus infection in Korea. Y Korean Med Sci 1993; 8: 395-404.","journal-title":"Y Korean Med Sci"},{"key":"ref_14","first-page":"168","article-title":"Natural history and survival rate of chronic liver diseases - 20 years' prospective analysis","volume":"46","author":"Kim, C.Y.; Kim, J.W.; Lee, H.S.; Yoon, Y.B.; Song, I.S.","year":"1994","unstructured":"Kim CY, Kim JW, Lee HS, Yoon YB, Song IS. Natural history and survival rate of chronic liver diseases - 20 years' prospective analysis. Korean Jf Med 1994; 46: 168-80.","journal-title":"Korean Jf Med"},{"key":"ref_15","article-title":"A cohort study on the causal association between hepatitis B virus infection and hepatocellular carcinoma with reference to the protective effect of vaccination against hepatitis B","author":"Lee, M.S.","year":"1995","unstructured":"Lee MS. A cohort study on the causal association between hepatitis B virus infection and hepatocellular carcinoma with reference to the protective effect of vaccination against hepatitis B [Thesis]. Seoul, Korea: Postgraduate School, Seoul National University, 1995."}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.38.Suppl_2.S63","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T01:51:52Z","timestamp":1765072312000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.38.Suppl_2.S63"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996]]},"references-count":15,"journal-issue":{"issue":"Suppl 2","published-online":{"date-parts":[[1996,1,1]]},"published-print":{"date-parts":[[1996]]}},"alternative-id":["10.1136\/gut.38.Suppl_2.S63"],"URL":"https:\/\/doi.org\/10.1136\/gut.38.suppl_2.s63","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"type":"print","value":"0017-5749"},{"type":"electronic","value":"1468-3288"}],"subject":[],"published":{"date-parts":[[1996]]}}}